Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Atanackovic · SciRah

Researcher profile · Semantic Scholar

D. Atanackovic

Share profile

D. Atanackovic — researcher profile on SciRah

h-index: 55
Works: 239
Citations: 7,062

Most-cited papers

Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
Shaji K. Kumar, N. Callander, M. Alsina, D. Atanackovic +25 more
2017The Journal of the National Comprehensive Cancer Network266 citations Open access
Semantic Scholar
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
M. Sebastian, Andreas Schröder, B. Scheel, H. Hong +22 more
2019Cancer Immunology and Immunotherapy182 citations
Semantic Scholar
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors
M. Kebenko, M. Goebeler, M. Wolf, A. Hasenburg +13 more
2018Oncoimmunology167 citations Open access
Semantic Scholar
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.
Shaji K. Kumar, Natalie S. Callander, M. Alsina, D. Atanackovic +26 more
2018The Journal of the National Comprehensive Cancer Network137 citations Open access
Semantic Scholar
Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion
Michael L. Olson, Erica R. Vander Mause, S. Radhakrishnan, J. Brody +4 more
2022Leukemia94 citations Open access
Semantic Scholar
Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients
S. Yousef, J. Marvin, M. Steinbach, A. Langemo +5 more
2015Blood Cancer Journal86 citations Open access
Semantic Scholar
Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma
Xiaomu Wei, M. N. Calvo-Vidal, Siwei Chen, Gang Wu +40 more
2018Cancer Research73 citations Open access
Semantic Scholar
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
J. Mikhael, Karim Belhadj-Merzoug, C. Hulin, L. Vincent +17 more
2021Blood Cancer Journal72 citations Open access
Semantic Scholar
NCCN Guidelines® Insights Multiple Myeloma, Version 3.2016
Kenneth C. Anderson, M. Alsina, D. Atanackovic, J. S. Biermann +25 more
2016The Journal of the National Comprehensive Cancer Network72 citations Open access
Semantic Scholar
Role of immunotherapy in Ewing sarcoma
Erin Morales, Michael L. Olson, Fiorella Iglesias, S. Dahiya +2 more
2020Journal for ImmunoTherapy of Cancer70 citations Open access
Semantic Scholar
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide
S. Radhakrishnan, T. Luetkens, Sandra D. Scherer, Patricia Davis +10 more
2020Nature Communications69 citations Open access
Semantic Scholar
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO).
J. Vansteenkiste, F. Barlesi, C. Waller, J. Bennouna +15 more
2015Annals of Oncology68 citations Open access
Semantic Scholar
Multiple Myeloma, Version 2.2016
Kenneth C. Anderson, M. Alsina, D. Atanackovic, J. S. Biermann +25 more
2015The Journal of the National Comprehensive Cancer Network67 citations Open access
Semantic Scholar
Chimeric Antigen Receptor (CAR) therapy for multiple myeloma
D. Atanackovic, S. Radhakrishnan, Neelam Bhardwaj, T. Luetkens
2016British Journal of Haematology64 citations Open access
Semantic Scholar
Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium
Leah H. Schinasi, Elizabeth E. Brown, Nicola J. Camp, Sophia S. Wang +18 more
2016British Journal of Haematology58 citations Open access
Semantic Scholar
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non–Small-Cell Lung Cancer
J. Pujol, J. Vansteenkiste, T. De Pas, D. Atanackovic +14 more
2015Journal of Thoracic Oncology58 citations Open access
Semantic Scholar
B cell maturation antigen‐specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta‐analysis
N. Gagelmann, F. Ayuk, D. Atanackovic, N. Kroger
2019European Journal of Haematology56 citations
Semantic Scholar
Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
K. Bisht, T. Fukao, M. Chiron, Paul G. Richardson +5 more
2023Cancer Medicine44 citations Open access
Semantic Scholar
Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity.
Erica R. Vander Mause, D. Atanackovic, Carol S. Lim, T. Luetkens
2022Trends in Biotechnology43 citations
Semantic Scholar
Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk
Rosalie G. Waller, T. Darlington, Xiaomu Wei, M. Madsen +22 more
2017bioRxiv43 citations Open access
Semantic Scholar
Immunotherapies targeting CD38 in Multiple Myeloma
D. Atanackovic, M. Steinbach, S. Radhakrishnan, T. Luetkens
2016Oncoimmunology39 citations Open access
Semantic Scholar
A Dose Finding Phase II Trial of Isatuximab (SAR650984, Anti-CD38 mAb) As a Single Agent in Relapsed/Refractory Multiple Myeloma
T. Martin, J. Richter, R. Vij, Craig E. Cole +16 more
201536 citations Open access
Semantic Scholar
Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, anti-CD38 mAb) in relapsed/refractory multiple myeloma (RRMM).
J. Richter, T. Martin, R. Vij, Craig E. Cole +16 more
201634 citations
Semantic Scholar
In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab
D. Atanackovic, S. Yousef, Christa Shorter, S. Tantravahi +9 more
2019Leukemia33 citations
Semantic Scholar
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
P. Hendrickson, Michael L. Olson, T. Luetkens, S. Weston +3 more
2019Oncoimmunology32 citations Open access
Semantic Scholar
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity
Erica R. Vander Mause, Jillian M. Baker, Kenneth A. Dietze, S. Radhakrishnan +13 more
2023Science Translational Medicine31 citations
Semantic Scholar
CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma
S. Yousef, M. Kovacsovics-Bankowski, M. Salama, Neelam Bhardwaj +9 more
2015Human Vaccines & Immunotherapeutics31 citations Open access
Semantic Scholar
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell – depleted lymphoma after CART therapy
D. Atanackovic, T. Luetkens, Destiny Omili, Thierry Iraguha +20 more
202228 citations
Semantic Scholar
The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
Forat Lutfi, N. Holtzman, A. Kansagra, M. K. Mustafa Ali +18 more
2021British Journal of Haematology28 citations
Semantic Scholar
Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
T. Luetkens, R. Metcalf, V. Planelles, Yue Zheng +13 more
2020Blood Advances28 citations Open access
Semantic Scholar
Biomarkers for checkpoint inhibition in hematologic malignancies.
D. Atanackovic, T. Luetkens
2018Seminars in Cancer Biology28 citations
Semantic Scholar
Humoral immunity against SARS‐CoV‐2 variants including omicron in solid organ transplant recipients after three doses of a COVID‐19 mRNA vaccine
K. Saharia, J. Husson, Silke V. Niederhaus, Thierry Iraguha +23 more
2022Clinical & Translational Immunology26 citations Open access
Semantic Scholar
An anti-programmed death-1 antibody (αPD-1) fusion protein that self-assembles into a multivalent and functional αPD-1 nanoparticle
Peng Zhao, D. Atanackovic, Shu-Yun Dong, H. Yagita +2 more
2017Molecular Pharmaceutics26 citations Open access
Semantic Scholar
Novel anti-myeloma immunotherapies targeting the SLAM family of receptors
S. Radhakrishnan, Neelam Bhardwaj, T. Luetkens, D. Atanackovic
2017Oncoimmunology26 citations Open access
Semantic Scholar
A meta-analysis of multiple myeloma risk regions in African and European ancestry populations identifies putatively functional loci
K. Rand, Chi Song, Eric Déan, D. Serie +98 more
2016Cancer Epidemiology, Biomarkers and Prevention26 citations Open access
Semantic Scholar
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
S. Dahiya, T. Luetkens, Forat Lutfi, S. Avila +12 more
2021Blood Advances23 citations Open access
Semantic Scholar
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer
A. Stein, D. Atanackovic, B. Hildebrandt, Patrick Stübs +7 more
2015British Journal of Cancer23 citations Open access
Semantic Scholar
Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension
L. Harbaum, Emilia Renk, S. Yousef, Antonia Glatzel +9 more
2016BMC Pulmonary Medicine22 citations Open access
Semantic Scholar
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review
A. Mumtaz, Andrew Fischer, Forat Lutfi, Lisa R. Matsumoto +10 more
2022British Journal of Ophthalmology18 citations
Semantic Scholar
Pooled study of occupational exposure to aromatic hydrocarbon solvents and risk of multiple myeloma
A. De Roos, J. Spinelli, Elizabeth B. Brown, D. Atanackovic +21 more
2018Occupational and Environmental Medicine17 citations Open access
Semantic Scholar
The role of surface molecule CD229 in Multiple Myeloma.
Michael L. Olson, S. Radhakrishnan, T. Luetkens, D. Atanackovic
2019Clinical Immunology16 citations
Semantic Scholar
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non–Small Cell Lung Cancer
B. Dizier, A. Callegaro, M. Debois, B. Dréno +16 more
2019Clinical Cancer Research16 citations Open access
Semantic Scholar
Chimeric Antigen Receptor (CAR) T Cells Specific for CD229: A Potentially Curative Approach for Multiple Myeloma
S. Radhakrishnan, T. Luetkens, S. Yousef, Neelam Bhardwaj +5 more
201716 citations
Semantic Scholar
Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation
J. Templin, D. Atanackovic, Daniel Hasche, S. Radhakrishnan +1 more
2017OncoTarget15 citations Open access
Semantic Scholar
Imaging Biomarkers to Predict Outcomes in Patients With Large B-Cell Lymphoma With a Day 28 Partial Response by 18F-FDG PET/CT Imaging Following CAR-T Therapy.
Forat Lutfi, O. Goloubeva, Amer Kowatli, Anton A. Gryaznov +17 more
2023Clinical Lymphoma, Myeloma & Leukemia14 citations Open access
Semantic Scholar
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cells
Yamini K. Kathari, Haroon Ahmad, M. Kallen, R. Koka +21 more
2023Haematologica14 citations Open access
Semantic Scholar
T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine
D. Atanackovic, R. Kreitman, Jeffrey W. Cohen, N. Hardy +9 more
2022Journal for ImmunoTherapy of Cancer14 citations Open access
Semantic Scholar
Cancer‐testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma
N. Lajmi, T. Luetkens, S. Yousef, J. Templin +5 more
2015British Journal of Haematology14 citations Open access
Semantic Scholar
Deep dissection of the antiviral immune profile of patients with COVID-19
D. Atanackovic, S. Avila, Forat Lutfi, D. de Miguel-Pérez +16 more
2021Communications Biology12 citations Open access
Semantic Scholar
Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma.
D. Atanackovic, T. Luetkens, S. Radhakrishnan, N. Kroger
2017Current Cancer Drug Targets11 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Luetkens×25
Invite
T. Luetkens — researcher profile on SciRah
A. Rapoport×11
Invite
A. Rapoport — researcher profile on SciRah
S. Radhakrishnan×10
Invite
S. Radhakrishnan — researcher profile on SciRah
S. Dahiya×10
Invite
S. Dahiya — researcher profile on SciRah

×8

Invite

N. Hardy — researcher profile on SciRah

Invite

S. Yousef — researcher profile on SciRah

M. Steinbach×7

Invite

M. Steinbach — researcher profile on SciRah

Invite

K. Hankey — researcher profile on SciRah

C. Gasparetto×6

Invite

C. Gasparetto — researcher profile on SciRah

Michael L. Olson×6

Invite

Michael L. Olson — researcher profile on SciRah

Thierry Iraguha×6

Invite

Thierry Iraguha — researcher profile on SciRah

Invite

Forat Lutfi — researcher profile on SciRah